Specialty Pharmacy

CD40-antibody drugs could have enhanced anti-tumor activity.

Top news from across the health care landscape.

Drug efficacy varies in colorectal cancer dependent on where the tumor is located.

Specialty drugs accounted for nearly half of total drug spending from just 1.8% of total prescriptions filled.

Four major hepatitis genotypes kill more people than HIV, malaria, and tuberculosis.

Humulin R U-500 has been approved since 1994 for the treatment of diabetes, but a dedicated syringe did not previously exist.

Study reveals untapped potential of gene-editing tool.

Top news of the day from across the health care landscape.

Certain bacterial populations are increased or decreased in the presence of cancer.

A majority of patients with specific gene mutation will eventually relapse and die of treatment-resistant leukemia.

Syndros can be used to treat anorexia due to AIDS, and nausea and vomiting due to chemotherapy.

Treating modifiable risk factors could enhance breast cancer prevention.

Top articles of the week from The American Journal of Pharmacy Benefits.

Obstructive sleep apnea in MS patients can lead to deeper problems.

Anti-nausea and vomit medication could help reduce hospitalization in liver cancer.

Physicians caring for Medicaid patients will no longer receive payment bumps.

Antiretroviral therapy may alleviate some cognitive problems among HIV-positive patients.

Recent advances and updates in oncology and cancer drug development.

A more hands-on approach to patient care can improve overall outcomes.

MEDI4736 is an experimental human monoclonal antibody used against PDL1.

Adherence to a plant-based diet low in animal foods found to improve overall health.

Top news of the day from across the health care landscape.

Body mass index and smoking could have significant impact on RA remission.

Breast cancer cells found to hide in bone marrow before resurging.

Pancreatic cancer patients whose tumors surround critical blood vessels may have new treatment options.

Top articles of the week on Specialty Pharmacy Times.

Threat of legal action prompts several states to allow greater access to curative HCV drugs.

List prices for Complera and Stribild continue to rise for HIV treatment.

Too little or too much sleep can lead to inflammatory illnesses.

Immunotherapy for lung cancer patients may cause other conditions to become worse.